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Wendell A Lim
The structure of the Nef–SH3 domain complex reveals
how an SH3 domain can more effectively ‘read’ its
linear proline-rich recognition element when it is
presented within the context of a folded protein.
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In the complex society of the cell, decisions of cell fate are
made by committees of interacting proteins. Given the
seemingly limitless number of signalling proteins in an
individual cell, an intrinsic problem is how to maintain
order among them. As one solution to this problem, nature
has developed classes of modular protein–protein recogni-
tion domains [1,2]. These domains can recognize small
specific sequence elements in target proteins, thereby non-
covalently tethering proteins so that they can specifically
act together, or upon one another. One well-studied family
of domains comprises the Src homology 3 (SH3) domains,
which, as shown in early work by Baltimore and coworkers
[3], can recognize short proline-rich peptide sequences of
about 10 residues bearing the consensus PXXP.
SH3 domains: the specificity problem
Given that SH3 domains are postulated to mediate spe-
cific biological interactions, it was expected that individual
SH3 domains would exhibit distinct preferences for spe-
cific variations of the PxxP motif. This has not turned out
to be the case. Instead, SH3–peptide interactions have
been found to be highly promiscuous and relatively weak,
with affinities ranging from 5–100 mM [4]. Although com-
binatorial screening studies have revealed some prefer-
ences for specific residues flanking the core motif, these
preferences are relatively modest, and only seem to divide
the fifty or so known SH3 domains into several broad
specificity classes [5–7]. Thus, we are left with the initial
problem of how biological signalling specificity can be
achieved. Obviously, reduction of these interacting
systems to isolated domains and short peptides doesn’t
tell the entire story. Recent work on the HIV protein Nef
clearly shows that additional levels of specificity do exist.
The intact Nef protein is a highly specific ligand for the Hck
SH3 domain
Nef, which is critical for virulent progression of AIDS (see
[8] for review), has been shown to serve as a high affinity
ligand for the SH3 domains of the Src family kinases Hck
and Lyn, but not for the SH3 domains of the closely
related kinases Fyn and Lck [9]. The Hck SH3 binds Nef
with an affinity of 0.25 mM, the strongest SH3 interaction
measured to date [10]. 
As expected, Nef has a conserved PxxP motif, which is
essential for SH3 recognition as well as biological function.
Surprisingly, however, a short 12-residue peptide bearing
this sequence is only observed to have an affinity of
91 mM for Hck [10]. Thus, the affinity of the Hck SH3
domain for intact Nef is greater than 300 times that for the
Nef proline-rich peptide. Moreover, unlike intact Nef,
this isolated peptide does not show a strong discrimination
for Hck and against Fyn. 
Lee et al. [10] have found that a key determinant of high
affinity binding to intact Nef is a single isoleucine residue
found in both Hck and Lck, but not in Fyn. When the cor-
responding residue in Fyn, Arg96, is mutated to Ile (R96I),
the Fyn variant shows high specificity for intact Nef.
Structure of Nef and the Nef–SH3 complex
Two recent structures have revealed how this uniquely
specific SH3 interaction occurs. Grzesiek et al. [11] have
solved the NMR solution structure of the core of Nef
(residues 40–206, with a 159–170 deletion). Kuriyan and
colleagues have succeeded in crystallizing and solving the
structure of core Nef (residues 54–205) bound to the high
affinity R96I mutant of the Fyn SH3 domain [12]. 
In canonical SH3–peptide complexes, the core PxxP motif
adopts the left-handed polyproline II (PPII) helix, which
docks against a well-conserved, highly aromatic, PPII core
binding surface on the SH3 domain [13–19]. As a PPII helix
is pseudosymmetric, peptides have the potential to bind at
the SH3 core recognition surface in two possible orienta-
tions [13–14]. Surrounding the core surface are a number of
variable loops, including those referred to as the ‘RT-loop’
and the ‘n-src loop’ (Fig. 1). These regions can participate
in interactions with specific ligand residues flanking the
PXXP motif, and play a major role in determining the ori-
entation of binding. For example Src-type SH3 domains
have a well conserved glutamate at the end of the RT-loop,
which is often observed to interact with basic residues at
either termini of the peptide ligand. This leads to prefer-
ences for sequences of the type ‘RxxPxxP’ or ‘PxxPxR’.
These new structures show that the PxxP motif of Nef
(residues 71–78) adopts a PPII helix, just as observed for
isolated SH3 peptide ligands. Here, however, one face of
the PPII helix is packed against an a-helical portion of the
remaining Nef core (Fig. 1). Thus, the PPII helix is ‘pre-
sented’ to the SH3 domain in the context of a larger
protein surface. 
In the complex structure, the core recognition surface of
the SH3 domain is found to pack against the PPII helix of
Nef, precisely as observed with peptide ligands. What is
distinct about this complex, however, is that the RT loop
of the SH3 domain stretches over and beyond the PPII
helix to participate in additional tertiary interactions with
other parts of the Nef structure. Specifically, the key
specificity residue, Ile96, which is at the tip of the RT
loop, inserts into a complementary hydrophobic pocket
between two a helices of Nef. Thus, this SH3 domain
uses its non-conserved loop to ‘read’ elements of the Nef
structure that are sequentially non-contiguous with its
core, linear PxxP recognition element.
The origins of higher specificity and affinity
These tertiary interactions, involving the SH3 RT loop and
the Nef a helices, dramatically increase the overall foot-
print of the interface from ~780 Å2 to ~1200 Å2 (Fig. 2). In
addition to directly increasing the overall area of inter-
action, presentation of the PPII helix in the context of
intact Nef may also contribute indirectly to binding in
several ways. First, interaction with the rest of the Nef core
may help lock residues 71–78 in the PPII conformation.
Nearly one third of the PPII helix surface packs against the
remainder of Nef. The PPII helix appears to persist even
in the absence of SH3-domain binding [11]. In contrast,
spectroscopic studies have shown that most SH3-binding
peptides are only ~50% in the PPII conformation when
free in solution [4]. Second, the precise conformation and
position of key interacting residues within the PPII helix
appear to be more rigidly defined in intact Nef. For
example, Nef residue Arg77, which participates in a critical
interfacial electrostatic interaction with the SH3 domain, is
held in position by a network of interactions with other Nef
residues, thereby reducing the many degrees of freedom
normally present for a free arginine side chain. Thus, in
intact Nef, residues 71–78 are presented in the preferred
conformation for interaction with the SH3 domain. 
This contextual presentation of a proline-rich sequence to
a sequence-specific binding protein is in many ways remi-
niscent of the presentation of antigen peptides to the T-
cell receptor by MHC molecules. In the latter case, the
MHC ‘platter’ upon which the peptide is ‘served’ is postu-
lated to play a crucial role in correctly positioning peptide
residues, as well as participating directly in the recognition
interface [20,21]. Here Nef ‘serves’ the peptide to the SH3
domain in a preferable way.
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Figure 1
The structure of the Fyn (Arg96→Ile) SH3 domain complexed with
Nef [12], and comparison with the structure of the Sem-5 SH3
domain complexed with a proline-rich peptide from Sos [13]. The
SH3 domains are shown in purple, proline-rich core sequences are
shown in red, and the remainder of the Nef core (residues 79–205) in
orange. Regions N-terminal to Nef residue 71 are disordered in the
crystal structure. In both cases the core proline-rich sequence adopts
a polyproline II helix (indicated by a triangular prism) that docks at the
conserved binding surface. In the case of the interaction with Nef,
however, Ile96 (green), in the variable RT loop, packs between two
a helices in the Nef core. Coordinates for the Nef–SH3 complex were
kindly provided by J Kuriyan and C-H Lee.
Figure 2
The footprint of Nef on the SH3 domain. The surface occluded by the
proline-rich core peptide (residues 71–78) is outlined in magenta and
those occluded by the additional regions of the Nef core (residues
79–205) are outlined in green. Residue binding pockets along the
SH3 surface are numbered P—3 to P3 (see [7,13]). (Figure reproduced
from [12], with permission.)
Remaining questions
Is this tertiary, context-dependent mechanism of increased
specificity utilized by other biologically relevant SH3–
protein interactions? It is certainly possible. As can be seen
in Figure 1, both the RT and n-Src loops are placed in a
good position to interact with additional protein regions
that might pack against either apical face of a PPII helix
ligand. Thus, the residues on these highly variable loops
could potentially participate in a large assortment of ter-
tiary interactions that act in concert with the core PPII
recognition surface.
There are also alternative potential mechanisms for
increasing SH3 specificity. Multivalency, for example,
clearly plays an important role in raising the specificity of
the Src homology 2 (SH2) interactions of ZAP-70 [22] and
SH-PTP2 [23], each of which has two SH2 domains.
Multivalency may play a similar role in the higher affinity
of the double SH3 interactions of Grb2 (and its homologs
Sem-5 and Drk) with the multiple proline-rich sequences
found in Sos. 
If tertiary interactions do turn out to be a common mecha-
nism by which biologically relevant levels of specificity are
achieved, then it will be extremely difficult to clearly iden-
tify relevant, specific SH3 interaction partners by simple
sequence analysis, or simple screening experiments. Iden-
tification of target ligands moves from being a relatively
linear problem, to being one of three dimensions. 
These findings, however, open new avenues for the
design of SH3-targeted drugs. Pharmacological agents that
block the interactions of Nef with SH3 domains may
prove useful in slowing the progression of AIDS. With
these structures in hand it is clear that there are multiple
regions of the Nef–SH3 interface that could be targeted
for drug design, including regions that are distinct from
the PPII core binding site. Drugs that interfere at such
distinct sites may be considerably more specific than
drugs that interfere at the conserved PPII binding surface.
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